|
 |
|
 |
- May 2015 - European Patent Office publishes a Decision to Grant patent EP1773390B1 "Improved Therapeutic Agent for iNOS Generating Illness"
- October 2014 - Approval notice recieved from EPO for patent application number 05785042.2
- January 2014 - Neutralized iNOS-containing microvesicles with candidate aSeptiMab™ therapeutic.
- September 2013 - iNOS-containing microvesciles isolated from septic whole blood and demonstrated to be lethal
- May 2013 - Developed cell culture based efficacy assay for anti-MV-A iNOS mAb candidate therapy aSeptiMab™
- September 2012 - Filed PCT patent application with WIPO for Panel of Sepsis Biomarkers
- September 2012 - Dr. Webber named "Researcher of the Year" by NevBio
- July 2012 - Japanese Patent #5048207 issued extending in vitro diagnostic coverage
- September 2011 - Filed patent application with the USPTO for Panel of Sepsis Biomarkers
- October 2010 - Patent #EP1412471 extending in vitro diagnostic coverage issued in the UK, Ireland, Germany, France, Switzerland and Italy
- September 2009 – Notice of Allowance received from European Patent Office for “Apparatus and method for determining the onset and presence of sepsis conditions”
- April 2009 – Touro University of Nevada Medical School, Henderson, NV: Invited Research Lecture
- October 2008 – Nevada Biotechnology & Bioscience Consortium, Las Vegas, NV: Invited Research Presentation
- June 2008 – European Patent Office Patent # EP1012605 issued. "Immunoassay method employing monoclonal antibody reactive to human iNOS"
- May 2008 – Japan Patent Office Patent # 4117911 issued. "Immunoassay method employing monoclonal antibody reactive to human iNOS"
- May 2008 – LifeScienceFest 2008, University of California, Davis, CA: Invited Presentation
- May 2008 – BIO 2008 Business Forum, San Diego, CA: Invited Presentation
- April 2008 – Notice of Allowance received from Janapese Patent Office for “Immunoassay method employing monoclonal antibody reactive to human iNOS”
- February 2008 – Frost & Sullivan’s Venture Connection 2008, San Francisco, CA: Invited Presentation
- December 2007 - Analysis of clinical trial data shows plasma iNOS has a positive predictive value of greater than 96% for organ dysfunction associated with sepsis
- November 2007- Notice of Allowance received from European Patent Office for “Immunoassay method employing monoclonal antibody reactive to human iNOS”
- April 2007 - BioFinance 2007, Toronto, Canada: Invited Presentation
- April 2007 - U.S.A. Patent # 7,198,904 issued. “Immunoassay method employing monoclonal antibody reactive to human iNOS”
- November 2006 – Australian patent #2001280912 issued. “Apparatus and method for determining the onset and presence of sepsis conditions”
- September 2006 - 46th ICAAC conference, San Francisco, CA: Poster presentation
- September 2006 - Walter Reed Army Institute of Research, Washington, DC: Invited Presentation
- June 2006 - Tri-Service General Hospital, Taipei, Taiwan: Invited Lecture
- June 2006 - National Defense Medical Center, Taipei, Taiwan: Invited Lecture
- June 2006 - Academia Sinica, Institute of Biomedical Sciences, Taipei, Taiwan: Invited Lecture
- May 2006 - 27th American Society for Apheresis Conference, Las Vegas, NV: Poster presentation
|
|
|
|
|
|
